Impact of vancomycin and Clostridioides difficile on the secretome and pathogenicity of Clostridium innocuum.|https://dx.doi.org/10.1007/s00430-025-00831-5
Vancomycin Therapy for Induction and Maintenance of Remission in a Patient with Refractory Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case Report and Literature Review.|https://dx.doi.org/10.1159/000544161
Vancomycin Treatment for Pneumobilia in Clostridioides difficile Infection: A Case Analysis.|https://dx.doi.org/10.12659/AJCR.947628
The sigma factor Ïƒ(54) (rpoN) functions as a global regulator of antibiotic resistance, motility, metabolism, and virulence in Clostridioides difficile.|https://dx.doi.org/10.3389/fmicb.2025.1569627
Comparison of ceftriaxone versus ceftaroline in combination with ampicillin or penicillin against Enterococcus faecalis.|https://dx.doi.org/10.1128/spectrum.02718-24
Does the use of pulsed-xenon ultraviolet light reduce the risk of healthcare-associated infections?: An updated systematic review and meta-analysis.|https://dx.doi.org/10.1016/j.jiac.2025.102729
